U.S. Surgical Sutures Market (2025 - 2030)

U.S. Surgical Sutures Market Summary

An aging population with chronic conditions such as diabetes and cardiovascular diseases is further boosting demand for effective wound closure solutions. The U.S. surgical sutures industry is experiencing robust growth, driven by several key factors. The increasing prevalence of chronic diseases, a growing geriatric population, and advancements in surgical techniques are significantly boosting the demand for surgical sutures. Technological innovations, such as the development of absorbable and antimicrobial sutures, are enhancing surgical outcomes and patient recovery times. Furthermore, the expansion of Ambulatory Surgery Centers (ASCs) is enabling more outpatient procedures, further boosting the need for effective wound closure solutions. The U.S. performed 6.1 million surgical procedures, highlighting the scale of demand for advanced suturing products.

Government policies and regulations are crucial in shaping the U.S. surgical sutures industry. The U.S. Food and Drug Administration (FDA) oversees the classification and approval of surgical sutures, ensuring their safety and efficacy. Moreover, federal initiatives to improve healthcare infrastructure and support medical innovation contribute to market growth.

Market Concentration & Characteristics

The U.S. surgical sutures industry is characterized by a moderate to high degree of innovation, driven by advancements in materials such as absorbable, non-absorbable, barbed, and antimicrobial sutures.

Regulatory frameworks heavily influence the U.S. surgical sutures industry. In the U.S., surgical sutures are classified as Class II medical devices, requiring FDA approval and compliance with stringent safety and quality standards. While these regulations ensure patient safety and product efficacy, they can also extend product development timelines, impact market entry, and increase compliance costs for manufacturers. International regulations similarly shape U.S. market dynamics by controlling import, export, and clinical trial approvals.

Type Insights

The absorbable segment led the market with the largest revenue share of 60.8% in 2024 and is expected to record at the fastest CAGR over the forecast period. The rising demand for absorbable sutures is driven by their ability to temporarily support wounds during healing while withstanding normal stress and their natural biodegradability, making them a preferred choice among surgeons. DemeTECH Corporation, a U.S.-based company, specializes in high-performance absorbable surgical sutures for various procedures. Its portfolio includes DemeCRYL, DemeQUICK, DemeCAPRONE, DemeSORB, DemeDIOX, and DemeGUT, offering tailored absorption rates and optimal tissue support for soft tissue approximation and ligation. The sutures are fully absorbable and designed for reliability and minimal tissue reaction

The non-absorbable segment is projected to grow at a significant CAGR of 2.6% over the forecast period. This is due to its role in long-term tissue support procedures. These sutures are commonly used in cardiovascular, orthopedic, ophthalmic, and other surgeries, where permanent or extended wound closure is necessary. Nonabsorbable sutures remain in the tissue unless removed, providing durable strength and stability. The increasing volume of surgical procedures worldwide, driven by an aging population and rising prevalence of chronic conditions, has significantly contributed to the rising demand for non-absorbable sutures.

Filament Insights

The multifilament segment accounted for the largest market revenue share in 2024, due to its unique combination of clinical effectiveness, versatility, and surgeon preference. These sutures, made from multiple braided or twisted fibers, offer superior flexibility and ideal knot security, which makes them highly suitable for complex surgical procedures requiring reliable and secure wound closure. Their braided structure allows easier handling and manipulation during surgery, reducing operative time and enhancing precision, particularly in soft tissue approximation such as muscles, fascia, and ligaments.

The monofilament segment is projected to grow at the fastest CAGR over the forecast period. Monofilament sutures, composed of a single smooth strand, offer significant advantages such as reduced tissue trauma, minimal infection risk, and enhanced biocompatibility compared to multifilament sutures. Their non-capillary structure prevents fluid absorption and bacterial migration along the suture line, making them highly suitable for procedures where infection control is critical-such as cardiovascular, ophthalmic, and plastic surgeries. These characteristics align with the increasing global focus on improving patient safety and surgical outcomes. in February 2025, Meril, a Vapi-based medical device and technology company, expanded its cardiovascular portfolio by launching its monofilament surgical sutures, strengthening its focus on innovation, precision, and clinical excellence.

Application Insights

The general surgery segment accounted for the largest market revenue share in 2024. This category includes a diverse range of high-volume surgeries such as gastrointestinal surgeries-including bowel resections, gastric bypass, and colectomies-where sutures are vital for intestinal anastomosis and soft tissue closure to prevent leakage and ensure rapid healing. Appendectomies and hernia repairs (inguinal, umbilical, and ventral) also account for a significant share of general surgery procedures, driving continuous suture demand in both open and laparoscopic settings.

According to Healthcare Cost and Utilization Project data and the U.S. FDA, it is estimated that 611,000 ventral and 1 million inguinal hernia repairs are performed each year in the U.S. As per data published by the American Society of Anesthesiologists in 2024, Cholecystectomy, or gallbladder removal surgery, is one of the most common adult operations in the U.S., with over 1.2 million procedures performed annually.

The cardiovascular segment is anticipated to register at the fastest CAGR over the forecast period. The growth is driven by the rising prevalence of cardiovascular diseases worldwide and the increasing demand for complex heart surgeries. This segment includes high-value procedures such as coronary artery bypass grafting, valve replacements and repairs, aortic aneurysm repair, congenital heart defect corrections, and pacemaker or ICD lead placements, which require specialized sutures with superior tensile strength, durability, and biocompatibility. An increase in cardiovascular risk factors, such as hypertension, obesity, diabetes, and sedentary lifestyles, has led to a higher number of cardiac interventions.

Key U.S. Surgical Sutures Company Insights

Some key companies in the U.S. surgical sutures industry include Medtronic, Ethicon US, LLC., Dynarex Corporation, B. Braun SE, and others.

• Ethicon operates through two main business segments: Innovative Medicine and MedTech. The MedTech segment encompasses a diverse range of products within the cardiovascular, orthopedics, surgery, and vision categories. Specifically, the MedTech segment includes a comprehensive offering of products in the areas of surgery, orthopedics, cardiovascular health, and vision care, with the surgery segment focusing on wound closure solutions.

• Dynarex is a medical supply provider offering high-quality medical products and durable medical equipment of outstanding value, delivering an unmatched one-stop shopping experience. The company is expanding its presence with multiple warehouse locations across the U.S. and established distributor partnerships spanning all 50 states, as well as Canada, the Caribbean Islands, Central and South America, and the Middle East.

Recent Developments

• In October 2024, Corza Medical launched its Onatec ophthalmic microsurgical sutures at the Chicago American Academy of Ophthalmology (AAO) conference. The new line reflects Corza’s commitment to innovation in the ophthalmic surgery market, offering tailored, high-quality solutions to meet evolving clinical needs and strengthen its position as a trusted partner in eye care.

U.S. Surgical Sutures Market